KoBioLabs, Inc

A348150

KR7348150004

Food Processing

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
7,730 ^KRW	+1.31%		+2.79%	-9.17%

2022	5,607,000 Common Stock of KoBioLabs,Inc are subject to a Lock-Up Agreement Ending on 18-NOV-2022.	CI
2022	KoBioLabs, Inc announced that it has received KRW 10.000016 billion in funding from E-MART Inc.	CI

KoBioLabs, Inc announced that it has received KRW 10.000016 billion in funding from E-MART Inc.

April 05, 2022

On April 6, 2022, KoBioLabs, Inc closed the transaction.

Latest news about KoBioLabs, Inc

5,607,000 Common Stock of KoBioLabs,Inc are subject to a Lock-Up Agreement Ending on 18-NOV-2022.	22-11-17	CI
KoBioLabs, Inc announced that it has received KRW 10.000016 billion in funding from E-MART Inc.	22-04-05	CI
KoBioLabs to Raise $8 Million via Stock Offering	22-03-29	MT
KoBioLabs, Inc announced that it expects to receive KRW 10.000016 billion in funding from E-MART Inc.	22-03-28	CI
KoBioLabs, Inc announced that it has received KRW 6.99999775 billion in funding from Stonebridge Ventures Inc., Industrial Bank of Korea, Investment Arm and other investors	21-12-29	CI
KoBioLabs, Inc announced that it has received KRW 4.64999775 billion in funding	21-12-28	CI
KoBioLabs, Inc announced that it expects to receive KRW 6.99999775 billion in funding from Stonebridge Ventures Inc., Industrial Bank of Korea, Investment Arm and other investors	21-12-20	CI
KoBioLabs, Inc announced that it has received KRW 44.4498035 billion in funding from Jaedam Inc., Cornerstone Investment Partners Co., Ltd. and other investors	21-11-18	CI
1,130,196 Common Stock of KoBioLabs,Inc are subject to a Lock-Up Agreement Ending on 18-NOV-2021.	21-11-17	CI
Kobiolabs Targets Over $28 Million Through Stock Offering	21-11-10	MT
KoBioLabs, Inc announced that it expects to receive KRW 44.4498035 billion in funding from Jaedam Inc., Cornerstone Investment Partners Co., Ltd. and other investors	21-11-09	CI
KoBioLabs, Inc(KOSDAQ:A348150) added to S&P Global BMI Index	21-06-21	CI
213,600 Common Stock of KoBioLabs,Inc are subject to a Lock-Up Agreement Ending on 18-MAY-2021.	21-05-17	CI
840,158 Common Stock of KoBioLabs,Inc are subject to a Lock-Up Agreement Ending on 18-FEB-2021.	21-02-17	CI
845,970 Common Stock of KoBioLabs,Inc are subject to a Lock-Up Agreement Ending on 18-JAN-2021.	21-01-17	CI
2,525,978 Common Stock of KoBioLabs,Inc are subject to a Lock-Up Agreement Ending on 18-DEC-2020.	20-12-17	CI
KoBioLabs,Inc has completed an IPO in the amount of KRW 30 billion.	20-11-12	CI
KoBioLabs,Inc has filed an IPO.	20-07-03	CI
KoBioLabs, Inc announced that it has received KRW 4 billion in funding from CJ Cheiljedang Corporation	19-02-27	CI

KoBioLabs Inc is a Korea-based company mainly engaged in the development and sales of functional probiotics. The Company's products are sold under the names of Bioviom and Queens henna FOODOLOGY. The Company is also engaged in the development of new microbiome drugs. In addition, the Company engages in commissioned research. The Company sells its products in domestic and overseas markets.

Sector

Food Processing

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
KOBIOLABS, INC	-9.17%	106M
ZHEJIANG NHU COMPANY LTD.	+13.21%	8.15B
BELLRING BRANDS, INC.	-0.47%	7.23B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+12.30%	6.65B
BYHEALTH CO., LTD	-6.99%	3.72B
THE SIMPLY GOOD FOODS COMPANY	-7.20%	3.64B
XIAMEN KINGDOMWAY GROUP COMPANY	-4.78%	1.31B
SIRIO PHARMA CO., LTD.	+12.61%	972M
HERBALIFE LTD.	-43.12%	863M
USANA HEALTH SCIENCES, INC.	-15.02%	799M